LeaderPortfolio
Hamied
Yusuf Hamied
Rank #1663
INDIAHealthcarePharmaceuticals

Yusuf Hamied

Net Worth
$2.462B
+0.4% (24h)
Yusuf Khwaja Hamied, born in 1936, is an Indian scientist and billionaire businessman, most recognized as the non-executive chairman of Cipla, a leading pharmaceutical company. His career has been marked by his commitment to providing affordable healthcare, particularly in developing countries, by defying large pharmaceutical companies to offer generic drugs. With a net worth estimated at $2.5 billion as of 2024, he has received numerous awards, including the Padma Bhushan. Hamied's contributions extend beyond business, as he has supported education and healthcare initiatives.

How to read Yusuf Hamied's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Yusuf Hamied, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $2.462B alongside global rank #1663, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (INDIA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Yusuf Hamied was born on July 25, 1936, in Vilnius, Lithuania (then Poland). He was raised in Bombay (now Mumbai). His father, Khwaja Abdul Hamied, was an Indian Muslim, and his mother, Luba Derczanska, was a Russophone Lithuanian Jewish. He attended the Cathedral and John Connon School and St. Xavier's College in Mumbai before pursuing higher education in England.

Rise to Success

Hamied earned a BA in chemistry in 1957 and a PhD from Christ's College, Cambridge. He joined Cipla, founded by his father, and took over as chairman in 1989. His career is characterized by his efforts to make life-saving medications, especially for HIV/AIDS and other ailments, accessible to people in developing countries. He is known for providing affordable generic drugs, challenging the practices of large Western pharmaceutical companies. This earned him both recognition and controversy within the industry.

Key Business Strategies

Hamied pioneered the development of affordable, multi-drug combination pills for HIV/AIDS, tuberculosis, and asthma. His strategies involved expanding the production of bulk drugs and active pharmaceutical ingredients in India, thereby reducing costs and increasing access to medicine. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

Philanthropy

Hamied has been involved in several philanthropic initiatives. He has supported educational causes and contributed to healthcare facilities. He has made major donations to Cambridge University's chemistry department, including the foundation of the Hamied Scholars Programme. He also contributed to the IISER Pune for a state-of-the-art chemistry facility.

Career Timeline

1989

Chairman of Cipla

Became the Chairman of Cipla, continuing to lead the company's mission of providing affordable healthcare.

1976

Managing Director of Cipla

Became the Managing Director of Cipla.

1960

Joined Cipla

Joined the family business as a research officer after completing his PhD.

Philanthropic Impact

Education$0.02B

IISER Pune Chemistry Facility

Donated to IISER Pune for a state-of-the-art chemistry facility to be used in outreach programs.

EducationUnknown

Hamied Scholars Programme

Supported Cambridge University's chemistry department, leading to the foundation of the Hamied Scholars Programme.

Key Business Ventures & Holdings

CompanyStakeValue
Cipla33.61%

Net Worth History

In-Depth Analysis

Early Life

Yusuf Hamied was born on July 25, 1936, in Vilnius, Lithuania (then Poland). He was raised in Bombay (now Mumbai). His father, Khwaja Abdul Hamied, was an Indian Muslim, and his mother, Luba Derczanska, was a Russophone Lithuanian Jewish. He attended the Cathedral and John Connon School and St. Xavier's College in Mumbai before pursuing higher education in England.

Rise to Success

Hamied earned a BA in chemistry in 1957 and a PhD from Christ's College, Cambridge. He joined Cipla, founded by his father, and took over as chairman in 1989. His career is characterized by his efforts to make life-saving medications, especially for HIV/AIDS and other ailments, accessible to people in developing countries. He is known for providing affordable generic drugs, challenging the practices of large Western pharmaceutical companies. This earned him both recognition and controversy within the industry.

Key Business Strategies

Hamied pioneered the development of affordable, multi-drug combination pills for HIV/AIDS, tuberculosis, and asthma. His strategies involved expanding the production of bulk drugs and active pharmaceutical ingredients in India, thereby reducing costs and increasing access to medicine. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

Philanthropy

Hamied has been involved in several philanthropic initiatives. He has supported educational causes and contributed to healthcare facilities. He has made major donations to Cambridge University's chemistry department, including the foundation of the Hamied Scholars Programme. He also contributed to the IISER Pune for a state-of-the-art chemistry facility.

Data Sources & Methodology

Figures for Yusuf Hamied are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.